Literature DB >> 7983076

Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor.

M no1, G Raab, K Lau, J A Abraham, M Klagsbrun.   

Abstract

Heparin-binding epidermal growth factor-like growth factor (HB-EGF), whose cDNA has a predicted 208-codon open reading frame, is synthesized as a membrane-spanning precursor that is processed to release mature mitogenic proteins of approximately 73-87 amino acids in length. Previous work has focused on the structural and biological properties of secreted HB-EGF. In this study, human recombinant transmembrane HB-EGF, produced by expression of HB-EGF1-208 cDNA in a baculovirus system, has been isolated, purified, and characterized structurally and biologically. Two isoforms of transmembrane HB-EGF (HB-EGFTM) were purified from membrane fractions of infected insect cells by a combination of heparin affinity chromatography and reversed-phase high performance liquid chromatography. The isoform designated as HB-EGFTM-1, a 21.5-kDa protein, yielded no N-terminal sequence, suggesting that it is N-terminally blocked. However, HB-EGFTM-II, a 24-kDa protein, was N-terminally sequenced and found to be initiated at Asp63 in the 208-amino acid residue primary translation product. This N terminus is the same as that determined for a 18-kDa isoform of secreted HB-EGF purified from the conditioned medium of insect cells expressing HB-EGF1-149 cDNA and is also identical to the N terminus of the longest form of secreted HB-EGF initially purified from human macrophage-like U-937 cell conditioned medium. HB-EGFTM-II cross-reacted on a Western blot with an antibody directed against the 16 C-terminal amino acids of the cytoplasmic tail of HB-EGF, indicating that it contains a putative transmembrane domain. HB-EGFTM-II was bioactive and stimulated the proliferation of BALB/c 3T3 cells and smooth muscle cells and the motility of smooth muscle cells, albeit with approximately 10-25% of the specific activity of secreted HB-EGF isoforms. We concluded that transmembrane HB-EGF is bioactive when isolated, consistent with the possibility of its functioning as a juxtacrine growth factor when still tethered to the cell.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983076

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

Authors:  Nadia Nour; Gaétan Mayer; John S Mort; Alexandre Salvas; Majambu Mbikay; Charlotte J Morrison; Christopher M Overall; Nabil G Seidah
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

2.  Baculovirus expression of the respiratory syncytial virus fusion protein using Trichoplusia ni insect cells.

Authors:  M Parrington; S Cockle; P Wyde; R P Du; E Snell; W Y Yan; Q Wang; L Gisonni; S Sanhueza; M Ewasyshyn; M Klein
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor.

Authors:  J Dong; L K Opresko; P J Dempsey; D A Lauffenburger; R J Coffey; H S Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

4.  Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules.

Authors:  M Sakai; M Zhang; T Homma; B Garrick; J A Abraham; J A McKanna; R C Harris
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

5.  Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats.

Authors:  L Feng; G E Garcia; Y Yang; Y Xia; F B Gabbai; O W Peterson; J A Abraham; R C Blantz; C B Wilson
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode.

Authors:  Jianying Dong; Lee K Opresko; William Chrisler; Galya Orr; Ryan D Quesenberry; Douglas A Lauffenburger; H Steven Wiley
Journal:  Mol Biol Cell       Date:  2005-04-13       Impact factor: 4.138

7.  Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action.

Authors:  L A Opanashuk; R J Mark; J Porter; D Damm; M P Mattson; K B Seroogy
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

8.  Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.

Authors:  K Goishi; S Higashiyama; M Klagsbrun; N Nakano; T Umata; M Ishikawa; E Mekada; N Taniguchi
Journal:  Mol Biol Cell       Date:  1995-08       Impact factor: 4.138

9.  The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages.

Authors:  Justin P Edwards; Xia Zhang; David M Mosser
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

10.  ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.

Authors:  Yuriko Iwakura; Hiroyuki Nawa
Journal:  Front Cell Neurosci       Date:  2013-02-13       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.